Showing 6231-6240 of 23149 results for "".
Isolated Distal DVT in Cancer Cells for Longer DOAC Treatment
https://reachmd.com/cme/pace-cme/isolated-distal-dvt-cancer-cells-longer-doac-treatment/16003/Here's a recap of the ONCO DVT trial, as presented at the 2023 ESC Congress.Standardized Screening Tools for AUD
https://reachmd.com/programs/cme/standardized-screening-tools-for-aud/15212/TBDSelecting an AUD Treatment: Acamprosate
https://reachmd.com/programs/cme/selecting-an-aud-treatment-acamprosate/15217/TBDThe FDA Expands Indication for Baloxavir Marboxil to Include Post-Exposure Influenza Prevention
https://reachmd.com/programs/the-drug-report/the-fda-expands-indication-for-baloxavir-marboxil-to-include-post-exposure-influenza-prevention/12043/Previously used for acute uncomplicated influenza, baloxavir marboxil has been approved by the FDA for post-exposure influenza prevention.Easing the Burden of Medicare Documentation Guidelines
https://reachmd.com/programs/perspectives-ama/easing-the-burden-of-medicare-documentation-guidelines/10608/Even amid the recent proposed changes to the documentation rules for office visits, organized medicine is working to reduce this burden on physicians.Are We Prepared for MACRA and the Quality Payment Program? The Survey Says . . .
https://reachmd.com/programs/perspectives-ama/are-we-prepared-for-macra-and-the-quality-payment-program-survey-says/9693/Guest experts from the AMA and KPMG share their survey results revealing how prepared physicians really are for MACRA and the QPP.Radiation Therapy & Prostate Imaging
https://reachmd.com/programs/clinicians-roundtable/radiation-therapy-prostate-imaging/3166/Keeping closer tabs on the intrafractional movement of the prostate during radiation therapy will continue to play an increasingly significant role in improving our overall success when treating prostate cancer. So says Dr. Charles Enke, professor and chair of radiation oncology at the University ofImproving adherence to medical therapy
https://reachmd.com/programs/clinicians-roundtable/improving-adherence-to-medical-therapy/895/Dr. Michael Murray, Professor and Chair of Pharmacuetical Outcomes and Policy at North Carolina, will describe a recent study that showed increased medication compliance with simple pharmacy intervnetions.Hepatocellular Carcinoma: Evaluating the Evolving Treatment Landscape
https://reachmd.com/programs/project-oncology/hepatocellular-carcinoma-evaluating-the-evolving-treatment-landscape/13526/Learn more about the latest updates—and what's on the horizon—for the treatment of hepatocellular carcinoma.Multidisciplinary Collaboration Facilitates Multimodality Therapy
https://reachmd.com/programs/cme/multidisciplinary-collaboration-facilitates-multimodality-therapy/36636/Explore perioperative immunotherapy and multimodal strategies to optimize patient outcomes in resectable locally advanced head and neck squamous cell carcinoma.